Stock 002653 HAISCO PHARMACEUTICAL GROUP CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Haisco Pharmaceutical Group Co., Ltd.

Equities

002653

CNE100001BC7

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-05-30 pm EDT 		5-day change 1st Jan Change
30.64 CNY -0.13% Intraday chart for Haisco Pharmaceutical Group Co., Ltd. +2.61% +32.35%
May. 16 Chinese Drug Regulator Accepts Haisco Pharma's Application for Pulmonary Disease Drug MT
Apr. 19 Haisco Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Other languages

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Chinese Drug Regulator Accepts Haisco Pharma's Application for Pulmonary Disease Drug
Haisco Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
Haisco Pharmaceutical Gets Nod to Trial HSK16149 Capsules
Haisco Pharma Gets Nod to Trial Asthma Drug
Haisco Pharma Gets Nod to Trial HSK16149 Capsule as Central Neuropathic Pain Drug
Haisco Pharma's Unit Gets Nod to Trial Drug for Hemolytic Diseases
Haisco Pharma's Unit Gets Nod to Trial Tumor Drug Candidate
Haisco Pharma to Set Up New Subsidiary in China’s Tibet Region
Haisco Pharmaceutical Signs $462 Million Deal with Italy’s Chiesi Farmaceutici
Haisco Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
Haisco Pharmaceutical Group Co., Ltd. Announces Management Changes
Haisco Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
Haisco Pharmaceutical's Unit Gets Greenlight to Trial Diabetes Drug
Haisco Pharma's Rupatadine Fumarate Tablets Passes Regulator's Evaluation
Haisco Pharma’s Blood Clot Drug Passes Generic Consistency Evaluation in China
Haisco Pharma Unit Gets Certification for Formula Food
Haisco Pharma Gets Nod for HSK31679 Tablet Trial
Haisco Pharma Unit Registers Nutritional Formula Food
Haisco Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
Haisco Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 002653 Stock
  4. News Haisco Pharmaceutical Group Co., Ltd.
  5. Other languages